Topics:

HIV AIDS

Rage, Rage Against the Dying of the Light

HIV infection had ravaged Amber's immune system, but not her spirit. Here: her story told by the physician who continues to walk with her.

HIV AIDS

A once daily MVC plus DRV/r regimen had an effective role in antiretroviral drug-pretreated individuals with controlled HIV infection in this trial. In an aging HIV-infected population, with increasing comorbidities, this combination could be a safer option than standard triple therapy. More here.

It now seems probable that most people with HCV infection can be cured—even if they are co-infected with HIV. But the "cost" of cure is expensive. This author concludes that many new regimens are cost effective and should not be withheld or made difficult to obtain by insurance companies and other payors.

A pseudo-tampon that delivers an antiretroviral drug is now being studied as a form of pre-exposure prophylaxis for women at high risk for HIV infection.

A new study found a high rate of peripheral neuropathy in antiretroviral-naive patients within 3 months after HIV infection.

The largest record linkage study to examine an association between the diseases could open inquiry into a protective effect greater than any factor yet observed for development of MS.

A recent study found that coinfection with cytomegalovirus and HIV was an independent risk factor for cerebrovascular and cardiovascular events.

This study demonstrates an added benefit to tenofovir-based preexposure prophylaxis regimens in preventing HSV-2.

Pages

Subscribe to HIV AIDS on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.